ASH 2019: Anthracyclines Benefit Older Patients With Classical Hodgkin Lymphoma
A real-world study suggests that age alone should not be a barrier to use these effective agents
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.